ImpediMed Limited's (ASX:IPD) non-executive director Martin Kriewaldt has acquired 200,000 shares in indirect interest via the on market purchase by Klemzig Pty Ltd, a company in which he has the power to influence the voting and disposal of shares.
The 200,000 shares were bought on market for a consideration of $16,220, with each share valued at $0.0811.
Klemzig has previously held 250,582 ordinary shares, and after the on market transaction, it now holds 450,582 shares.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.